These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1548 related articles for article (PubMed ID: 33167965)

  • 21. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
    Clift AK; Coupland CAC; Keogh RH; Diaz-Ordaz K; Williamson E; Harrison EM; Hayward A; Hemingway H; Horby P; Mehta N; Benger J; Khunti K; Spiegelhalter D; Sheikh A; Valabhji J; Lyons RA; Robson J; Semple MG; Kee F; Johnson P; Jebb S; Williams T; Hippisley-Cox J
    BMJ; 2020 Oct; 371():m3731. PubMed ID: 33082154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frailty in rheumatoidrmdopen-2021-002111 arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank.
    Hanlon P; Morton F; Siebert S; Jani BD; Nicholl BI; Lewsey J; McAllister D; Mair FS
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35292529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people.
    Miles A; Webb TE; Mcloughlin BC; Mannan I; Rather A; Knopp P; Davis D
    Eur Geriatr Med; 2020 Oct; 11(5):851-855. PubMed ID: 32683576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople).
    Carter B; Collins JT; Barlow-Pay F; Rickard F; Bruce E; Verduri A; Quinn TJ; Mitchell E; Price A; Vilches-Moraga A; Stechman MJ; Short R; Einarsson A; Braude P; Moug S; Myint PK; Hewitt J; Pearce L; McCarthy K;
    J Hosp Infect; 2020 Oct; 106(2):376-384. PubMed ID: 32702463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study].
    Georges JL; Cochet H; Roger G; Ben Jemaa H; Soltani J; Azowa JB; Mamou R; Gilles F; Saba J; Prevot A; Pasqualini M; Monguillon V; De Tournemire M; Bertrand A; Koukabi-Fradelizi M; Beressi JP; Livarek B
    Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):247-254. PubMed ID: 33039120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessing frailty in care practices : quick reminders in the light of the Covid-19 pandemic].
    Busnel C; Perrier-Gros-Claude O; Ludwig C
    Rev Med Suisse; 2020 Jul; 16(699):1316-1318. PubMed ID: 32608590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.
    Chachkhiani D; Soliman MY; Barua D; Isakadze M; Villemarette-Pittman NR; Devier DJ; Lovera JF
    Clin Neurol Neurosurg; 2020 Oct; 197():106173. PubMed ID: 32877769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    McKeigue PM; Weir A; Bishop J; McGurnaghan SJ; Kennedy S; McAllister D; Robertson C; Wood R; Lone N; Murray J; Caparrotta TM; Smith-Palmer A; Goldberg D; McMenamin J; Ramsay C; Hutchinson S; Colhoun HM;
    PLoS Med; 2020 Oct; 17(10):e1003374. PubMed ID: 33079969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study.
    Chinnadurai R; Ogedengbe O; Agarwal P; Money-Coomes S; Abdurrahman AZ; Mohammed S; Kalra PA; Rothwell N; Pradhan S
    BMC Geriatr; 2020 Oct; 20(1):409. PubMed ID: 33066750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events.
    Cobos-Siles M; Cubero-Morais P; Arroyo-Jiménez I; Rey-Hernández M; Hernández-Gómez L; Vargas-Parra DJ; González-Fernández M; Cazorla-González M; Gabella-Martín M; Ruíz-Albi T; Berezo-García JA; García-Cruces-Méndez JF; Miramontes-González JP; Corral-Gudino L
    Intern Emerg Med; 2020 Nov; 15(8):1533-1544. PubMed ID: 32910363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
    Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
    BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors, Presentation, and Course of Coronavirus Disease 2019 in a Large, Academic Long-Term Care Facility.
    Shi SM; Bakaev I; Chen H; Travison TG; Berry SD
    J Am Med Dir Assoc; 2020 Oct; 21(10):1378-1383.e1. PubMed ID: 32981664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of Severity of Depressive Symptoms Among At-Risk Groups in the UK During the COVID-19 Pandemic.
    Iob E; Frank P; Steptoe A; Fancourt D
    JAMA Netw Open; 2020 Oct; 3(10):e2026064. PubMed ID: 33104209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do lifestyle measures to counter COVID-19 affect frailty rates in elderly community dwelling? Protocol for cross-sectional and cohort study.
    Shinohara T; Saida K; Tanaka S; Murayama A
    BMJ Open; 2020 Oct; 10(10):e040341. PubMed ID: 33051236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
    Swann OV; Holden KA; Turtle L; Pollock L; Fairfield CJ; Drake TM; Seth S; Egan C; Hardwick HE; Halpin S; Girvan M; Donohue C; Pritchard M; Patel LB; Ladhani S; Sigfrid L; Sinha IP; Olliaro PL; Nguyen-Van-Tam JS; Horby PW; Merson L; Carson G; Dunning J; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
    BMJ; 2020 Aug; 370():m3249. PubMed ID: 32960186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for severe illness in hospitalized Covid-19 patients at a regional hospital.
    Turcotte JJ; Meisenberg BR; MacDonald JH; Menon N; Fowler MB; West M; Rhule J; Qureshi SS; MacDonald EB
    PLoS One; 2020; 15(8):e0237558. PubMed ID: 32785285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.